Position in PMVP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$142,431
-$16,370 QoQ
Shares Held
114,864
-9.6% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. PMVP ranks #328 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in PMVP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $142,431 | 114,864 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $158,801 | 127,041 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $239,122 | 170,802 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $100,777 | 95,073 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $98,386 | 90,263 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $183,079 | 121,245 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $759,905 | 510,004 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,310,165 | 808,744 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,861,924 | 1,095,250 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,488,911 | 802,875 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,793,033 | 943,491 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,000,421 | 639,045 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,117,818 | 653,631 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,289,164 | 607,950 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $6,264,921 | 526,464 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $6,796,309 | 476,934 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $8,703,696 | 418,045 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,757,490 | 249,242 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $8,756,431 | 293,840 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $5,307,677 | 155,377 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,659,517 | 80,861 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $5,955,160 | 167,751 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||